218 related articles for article (PubMed ID: 38201930)
1. The Role of Nicotinamide as Chemo-Preventive Agent in NMSCs: A Systematic Review and Meta-Analysis.
Tosti G; Pepe F; Gnagnarella P; Silvestri F; Gaeta A; Queirolo P; Gandini S
Nutrients; 2023 Dec; 16(1):. PubMed ID: 38201930
[TBL] [Abstract][Full Text] [Related]
2. Effect of Nicotinamide in Skin Cancer and Actinic Keratoses Chemoprophylaxis, and Adverse Effects Related to Nicotinamide: A Systematic Review and Meta-Analysis.
Mainville L; Smilga AS; Fortin PR
J Cutan Med Surg; 2022; 26(3):297-308. PubMed ID: 35134311
[TBL] [Abstract][Full Text] [Related]
3. Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients.
Allen NC; Martin AJ; Snaidr VA; Eggins R; Chong AH; Fernandéz-Peñas P; Gin D; Sidhu S; Paddon VL; Banney LA; Lim A; Upjohn E; Schaider H; Ganhewa AD; Nguyen J; McKenzie CA; Prakash S; McLean C; Lochhead A; Ibbetson J; Dettrick A; Landgren A; Allnutt KJ; Allison C; Davenport RB; Mumford BP; Wong B; Stagg B; Tedman A; Gribbin H; Edwards HA; De Rosa N; Stewart T; Doolan BJ; Kok Y; Simpson K; Low ZM; Kovitwanichkanont T; Scolyer RA; Dhillon HM; Vardy JL; Chadban SJ; Bowen DG; Chen AC; Damian DL
N Engl J Med; 2023 Mar; 388(9):804-812. PubMed ID: 36856616
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention.
Chen AC; Martin AJ; Choy B; Fernández-Peñas P; Dalziell RA; McKenzie CA; Scolyer RA; Dhillon HM; Vardy JL; Kricker A; St George G; Chinniah N; Halliday GM; Damian DL
N Engl J Med; 2015 Oct; 373(17):1618-26. PubMed ID: 26488693
[TBL] [Abstract][Full Text] [Related]
6. Sun protection for preventing basal cell and squamous cell skin cancers.
Sánchez G; Nova J; Rodriguez-Hernandez AE; Medina RD; Solorzano-Restrepo C; Gonzalez J; Olmos M; Godfrey K; Arevalo-Rodriguez I
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD011161. PubMed ID: 27455163
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Systematic Review.
Schauder DM; Kim J; Nijhawan RI
JAMA Dermatol; 2020 Oct; 156(10):1117-1124. PubMed ID: 32639538
[TBL] [Abstract][Full Text] [Related]
8. Nicotinamide for skin cancer chemoprevention.
Damian DL
Australas J Dermatol; 2017 Aug; 58(3):174-180. PubMed ID: 28321860
[TBL] [Abstract][Full Text] [Related]
9. Niacin intake and risk of skin cancer in US women and men.
Park SM; Li T; Wu S; Li WQ; Weinstock M; Qureshi AA; Cho E
Int J Cancer; 2017 May; 140(9):2023-2031. PubMed ID: 28152570
[TBL] [Abstract][Full Text] [Related]
10. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group.
Karagas MR; McDonald JA; Greenberg ER; Stukel TA; Weiss JE; Baron JA; Stevens MM
J Natl Cancer Inst; 1996 Dec; 88(24):1848-53. PubMed ID: 8961975
[TBL] [Abstract][Full Text] [Related]
11. Melanoma and nonmelanoma skin cancer chemoprevention: A role for nicotinamide?
Minocha R; Damian DL; Halliday GM
Photodermatol Photoimmunol Photomed; 2018 Jan; 34(1):5-12. PubMed ID: 28681504
[TBL] [Abstract][Full Text] [Related]
12. Nicotinamide: An Update and Review of Safety & Differences from Niacin.
Huber R; Wong A
Skin Therapy Lett; 2020 Nov; 25(5):7-11. PubMed ID: 33196157
[TBL] [Abstract][Full Text] [Related]
13. Prevention of non-melanoma skin cancers with nicotinamide in transplant recipients: a case-control study.
Drago F; Ciccarese G; Cogorno L; Calvi C; Marsano LA; Parodi A
Eur J Dermatol; 2017 Aug; 27(4):382-385. PubMed ID: 28468736
[TBL] [Abstract][Full Text] [Related]
14. Oral nicotinamide: The role in skin cancer chemoprevention.
Giacalone S; Spigariolo CB; Bortoluzzi P; Nazzaro G
Dermatol Ther; 2021 May; 34(3):e14892. PubMed ID: 33595161
[TBL] [Abstract][Full Text] [Related]
15. Oral nicotinamide for non-melanoma skin cancers: A review.
Hunt SV; Jamison A; Malhotra R
Eye (Lond); 2023 Apr; 37(5):823-829. PubMed ID: 35347291
[TBL] [Abstract][Full Text] [Related]
16. Nicotinamide for skin cancer chemoprevention: effects of nicotinamide on melanoma in vitro and in vivo.
Malesu R; Martin AJ; Lyons JG; Scolyer RA; Chen AC; McKenzie CA; Madore J; Halliday GM; Damian DL
Photochem Photobiol Sci; 2020 Feb; 19(2):171-179. PubMed ID: 31942903
[TBL] [Abstract][Full Text] [Related]
17. Epithelial skin cancers after kidney transplantation: a retrospective single-centre study of 376 recipients.
Kaufmann RA; Oberholzer PA; Cazzaniga S; Hunger RE
Eur J Dermatol; 2016 Jun; 26(3):265-70. PubMed ID: 26985913
[TBL] [Abstract][Full Text] [Related]
18. Incidence and prevalence of non-melanoma skin cancer in Australia: A systematic review.
Perera E; Gnaneswaran N; Staines C; Win AK; Sinclair R
Australas J Dermatol; 2015 Nov; 56(4):258-67. PubMed ID: 25716064
[TBL] [Abstract][Full Text] [Related]
19. Risk of skin cancer development in 672 patients affected by actinic keratosis.
Dika E; Fanti PA; Misciali C; Vaccari S; Crisman G; Barisani A; Baraldi C; Ribero S; Patrizi A
G Ital Dermatol Venereol; 2016 Dec; 151(6):628-633. PubMed ID: 26381460
[TBL] [Abstract][Full Text] [Related]
20. A randomized, 12-year primary-prevention trial of beta carotene supplementation for nonmelanoma skin cancer in the physician's health study.
Frieling UM; Schaumberg DA; Kupper TS; Muntwyler J; Hennekens CH
Arch Dermatol; 2000 Feb; 136(2):179-84. PubMed ID: 10677093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
